The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
Abstract
Primary tumors are responsible for 10% of cancer deaths. In most cases, the main cause of mortality is the formation of metastases. Accumulating evidence suggests that a subpopulation of tumor cells with distinct stem‐like properties is responsible for tumor initiation, invasive growth, and metastasis formation. This population is defined as cancer stem cells (CSCs). Existing therapies have enhanced the length of survival after diagnosis of cancer but have completely failed in terms of recovery. CSCs appear to be resistant to chemotherapy, may remain quiescent for extended periods, and have affinity for hypoxic environments. The CSCs can be identified and isolated by different methodologies, including isolation by CSC‐specific cell surface marker expression, detection of side population phenotype by Hoechst 33342 exclusion, assessment of their ability to grow as floating spheres, and aldehyde dehydrogenase (ALDH) activity assay. None of the methods mentioned are exclusively used to isolate the solid tumor CSCs, highlighting the imperative to delineate more specific markers or to use combinatorial markers and methodologies. This review provides an overview of the main characteristics and approaches used to identify, isolate, and characterize CSCs from solid tumors.—Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., Laino, L., De Francesco, F., Papaccio, G. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 27, 13–24 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression
Wei, J., Barr, J., Kong, L.-Y., Wang, Y., Wu, A., Sharma, A. K., Gumin, J., Henry, V., Colman, H., Sawaya, R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1983 · Cited by 221
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., Weissman, I. L., Clarke, M. F., & Ailles, L. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610117104 · Cited by 2,164
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5002 · Cited by 1,822
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Identification and expansion of the tumorigenic lung cancer stem cell population
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., & De Maria, R. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402283 · Cited by 1,707
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Identification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
A tumorigenic subpopulation with stem cell properties in melanomas
Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280
The Biology of Cancer Stem Cells
Lobo, N. A., Shimono, Y., Qian, D., & Clarke, M. F. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104154 · Cited by 1,043
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Takaishi, S., Okumura, T., Tu, S., Wang, S. S. W., Shibata, W., Vigneshwaran, R., Gordon, S. A. K., Shimada, Y., & Wang, T. C. (2009) · Stem Cells · doi:10.1002/stem.30 · Cited by 1,039
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K., & Clarke, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063994 · Cited by 985
Micalizzi, D. S., Farabaugh, S. M., & Ford, H. L. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9178-9 · Cited by 984
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
Pastrana, E., Silva-Vargas, V., & Doetsch, F. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.007 · Cited by 828
Bapat, S. A., Mali, A. M., Koppikar, C. B., & Kurrey, N. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3931 · Cited by 760
The Increasing Complexity of the Cancer Stem Cell Paradigm
Rosen, J. M., & Jordan, C. T. (2009) · Science · doi:10.1126/science.1171837 · Cited by 698
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Zeppernick, F., Ahmadi, R., Campos, B., Dictus, C., Helmke, B. M., Becker, N., Lichter, P., Unterberg, A., Radlwimmer, B., & Herold-Mende, C. C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0932 · Cited by 588
Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., RayChaudhury, A., Newton, H. B., Chiocca, E. A., & Lawler, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2629 · Cited by 587
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492
Cancer Stem Cells and Self-renewal
O'Brien, C. A., Kreso, A., & Jamieson, C. H. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2824 · Cited by 472
Virchow, V. R. (1861) · The American Journal of the Medical Sciences · doi:10.1097/00000441-186104000-00025 · Cited by 400
Sarry, J.-E., Murphy, K., Perry, R., Sanchez, P. V., Secreto, A., Keefer, C., Swider, C. R., Strzelecki, A.-C., Cavelier, C., Récher, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41495 · Cited by 386
Biddle, A., Liang, X., Gammon, L., Fazil, B., Harper, L. J., Emich, H., Costea, D. E., & Mackenzie, I. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1059 · Cited by 356
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Liu, M. C., Shields, P. G., Warren, R. D., Cohen, P., Wilkinson, M., Ottaviano, Y. L., Rao, S. B., Eng-Wong, J., Seillier-Moiseiwitsch, F., Noone, A.-M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6664 · Cited by 319
Circulating tumor cells: a window into cancer biology and metastasis
Maheswaran, S., & Haber, D. A. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.12.002 · Cited by 316
Identification of Cancer Stem Cells in Ewing's Sarcoma
Suvà, M.-L., Riggi, N., Stehle, J.-C., Baumer, K., Tercier, S., Joseph, J.-M., Suvà, D., Clément, V., Provero, P., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2242 · Cited by 302
Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours
Tirino, V., Desiderio, V., d'Aquino, R., De Francesco, F., Pirozzi, G., Galderisi, U., Cavaliere, C., De Rosa, A., & Papaccio, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003469 · Cited by 287
Self-citationA frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration
Maw, M. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.27 · Cited by 279
Adhikari, A. S., Agarwal, N., Wood, B. M., Porretta, C., Ruiz, B., Pochampally, R. R., & Iwakuma, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3463 · Cited by 261
Zhang, B., Strauss, A. C., Chu, S., Li, M., Ho, Y., Shiang, K.-D., Snyder, D. S., Huettner, C. S., Shultz, L., Holyoake, T., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.011 · Cited by 256
Nalls, D., Tang, S.-N., Rodova, M., Srivastava, R. K., & Shankar, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024099 · Cited by 256
MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma
Garzia, L., Andolfo, I., Cusanelli, E., Marino, N., Petrosino, G., De Martino, D., Esposito, V., Galeone, A., Navas, L., Esposito, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004998 · Cited by 255
Side Population Cells Isolated from Mesenchymal Neoplasms Have Tumor Initiating Potential
Wu, C., Wei, Q., Utomo, V., Nadesan, P., Whetstone, H., Kandel, R., Wunder, J. S., & Alman, B. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0999 · Cited by 221
Zhu, Y., Yu, F., Jiao, Y., Feng, J., Tang, W., Yao, H., Gong, C., Chen, J., Su, F., Zhang, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0071 · Cited by 221
Tirino, V., Camerlingo, R., Franco, R., Malanga, D., La Rocca, A., Viglietto, G., Rocco, G., & Pirozzi, G. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.03.063 · Cited by 213
Self-citationCancer stem cells and human malignant melanoma
Schatton, T., & Frank, M. H. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00427.x · Cited by 210
Stem cells, asymmetric division and cancer
Clevers, H. (2005) · Nature Genetics · doi:10.1038/ng1005-1027 · Cited by 201
Human primary bone sarcomas contain CD133 + cancer stem cells displaying high tumorigenicity in vivo
Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., Fazioli, F., Pirozzi, G., & Papaccio, G. (2011) · The FASEB Journal · doi:10.1096/fj.10-179036 · Cited by 201
Self-citationBreast cancer chemoresistance: Emerging importance of cancer stem cells
Chuthapisith, S., Eremin, J., El-Sheemey, M., & Eremin, O. (2010) · Surgical Oncology · doi:10.1016/j.suronc.2009.01.004 · Cited by 174
Identification and targeting of cancer stem cells
Schatton, T., Frank, N. Y., & Frank, M. H. (2009) · BioEssays · doi:10.1002/bies.200900058 · Cited by 174
The Molecular Basis of Pluripotency in Mouse Embryonic Stem Cells
Chambers, I. (2004) · Cloning and Stem Cells · doi:10.1089/clo.2004.6.386 · Cited by 173
Awad, O., Yustein, J. T., Shah, P., Gul, N., Katuri, V., O'Neill, A., Kong, Y., Brown, M. L., Toretsky, J. A., & Loeb, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013943 · Cited by 163
Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters
Özvegy‐Laczka, C., Cserepes, J., Elkind, N. B., & Sarkadi, B. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.02.002 · Cited by 157
Lung cancer stem cells: tools and targets to fight lung cancer
Eramo, A., Haas, T. L., & Maria, R. D. (2010) · Oncogene · doi:10.1038/onc.2010.207 · Cited by 155
Visús, C., Ito, D., Amoscato, A. A., Maciejewska-Franczak, M., Abdelsalem, A., Dhir, R., Shin, D. M., Donnenberg, V. S., Whiteside, T. L., & DeLeo, A. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1346 · Cited by 145
BMI1 as a novel target for drug discovery in cancer
Cao, L., Bombard, J., Cintron, K., Sheedy, J., Weetall, M. L., & Davis, T. W. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23234 · Cited by 144
Stem cells and cancer of the stomach and intestine
Vries, R. G. J., Huch, M., & Clevers, H. C. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.05.001 · Cited by 142
The ABCG2 resistance network of glioblastoma.
Bleau, A., Huse, J. T., & Holland, E. C. (2009) · PubMed · Cited by 138
Reim, F., Dombrowski, Y., Ritter, C., Buttmann, M., Häusler, S. F., Ossadnik, M., Krockenberger, M., Beier, D., Beier, C. P., Dietl, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0834 · Cited by 134
The ABCG2 resistance network of glioblastoma
Bleau, A., Huse, J. T., & Holland, E. C. (2009) · Cell Cycle · doi:10.4161/cc.8.18.9504 · Cited by 134
Role of Altered Expression of HLA Class I Molecules in Cancer Progression
Aptsiauri, N., Cabrera, T., Méndez, R., Garcia-Lor, A., Ruiz‐Cabello, F., & Garrido, F. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_13 · Cited by 132
ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?
Steinbach, D., & Legrand, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404692 · Cited by 127
Ouyang, G., Wang, Z., Fang, X., Liu, J., & Yang, C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0338-2 · Cited by 126
Wang, L., Park, P., Zhang, H., Marca, F. L., & Lin, C.-Y. J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25331 · Cited by 126
Murase, M., Kano, M., Tsukahara, T., Takahashi, A., Torigoe, T., Kawaguchi, S., Kimura, S., Wada, T., Uchihashi, Y., Kondo, T., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605330 · Cited by 123
The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-α Antitumor Effects
Moserle, L., Indraccolo, S., Ghisi, M., Frasson, C., Fortunato, E., Canevari, S., Miotti, S., Tosello, V., Zamarchi, R., Corradin, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6341 · Cited by 123
Chen, Y., Chang, C.-J., Hsu, H., Chen, Y., Tai, L.-K., Tseng, L., Chiou, G., Chang, S., Kao, S., Chiou, S., et al. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.11.007 · Cited by 120
Corbeil, D., Marzesco, A., Wilsch‐Bräuninger, M., & Huttner, W. Β. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.050 · Cited by 120
Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
Russo, J. E., & Hilton, A. (1988) · PubMed · Cited by 118
CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
Walter, D., Satheesha, S., Albrecht, P., Bornhauser, B. C., D’Alessandro, V., Oesch, S., Rehrauer, H., Leuschner, I., Kościelniak, E., Gengler, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019506 · Cited by 118
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
Mego, M., Giorgi, U. D., Dawood, S., Wang, X., Valero, V., Andreopoulou, E., Handy, B. C., Ueno, N. T., Reuben, J. M., & Cristofanilli, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25690 · Cited by 115
Rybak, A. P., He, L., Kapoor, A., Cutz, J., & Tang, D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.018 · Cited by 114
Die hard: Are cancer stem cells the Bruce Willises of tumor biology?
Fábián, Á., Barok, M., Vereb, G., & Szöllõsi, J. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20690 · Cited by 111
Human ovarian cancer stem cells
Bapat, S. A. (2010) · Reproduction · doi:10.1530/rep-09-0389 · Cited by 111
[Tumor stem cells and drug resistance].
Ou, Y., & Guo, X. (2007) · PubMed · Cited by 104
Circulating and Disseminated Tumor Cells in the Management of Breast Cancer
Ross, J. S., & Slodkowska, E. A. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpji7deolkcs6f · Cited by 91
Stem cells in squamous head and neck cancer
Albers, A. E., Chen, C., Köberle, B., Qian, X., Klußmann, J. P., Wollenberg, B., & Kaufmann, A. M. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.03.004 · Cited by 71
Kelly, S., Benedetto, A. D., Greco, A., Howard, C. M., Sollars, V. E., Primerano, D. A., Valluri, J. V., & Claudio, P. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010035 · Cited by 71
Methods for Cancer Stem Cell Detection and Isolation
Tirino, V., Desiderio, V., Paino, F., Papaccio, G., & ROSA, M. D. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-815-3_32 · Cited by 69
Self-citationHu, Z., Negrotto, S., Gu, X., Mahfouz, R., Ng, K. P., Ebrahem, Q., Copelan, E., Singh, H., Maciejewski, J. P., & Saunthararajah, Y. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0191 · Cited by 50 · cited 1×
“For instance, the demethylating agent 5-aza-2=-deoxycytidine has been shown to inhibit self-renewing population of CD34 cells (54).”
BackgroundDefining New Paradigms for the Treatment of Pancreatic Cancer
Almhanna, K., & Philip, P. A. (2011) · Current Treatment Options in Oncology · doi:10.1007/s11864-011-0150-8 · Cited by 40
Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Dunning, N. L., Laversin, S. A., Miles, A. K., & Rees, R. C. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1065-8 · Cited by 28
Cancer stem cells in urologic cancers
Gedye, C. A., Davidson, A., Elmes, M. R., Cebon, J. S., Bolton, D. M., & Davis, I. D. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.06.010 · Cited by 11
(2003) · PubMed
Cited by
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Picon‐Ruiz, M., Morata‐Tarifa, C., Valle‐Goffin, J. J., Friedman, E. R., & Slingerland, J. M. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21405 · Cited by 893
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
Sun, Z., Yang, S., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., Xu, J., Xia, K., Chang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0831-z · Cited by 427
Chen, W.-J., Ho, C.-C., Chang, Y.-L., Chen, H.-Y., Lin, C.-A., Ling, T.-Y., Yu, S.-L., Yuan, S.-S., Louisa Chen, Y.-J., Lin, C.-Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4472 · Cited by 422
Metadata
- Authors
- Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., Laino, L., De Francesco, F., & Papaccio, G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-09-28
- Volume
- 27
- Issue
- 1
- Pages
- 13-24
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2135943905
- Cited by
- 395
- References
- 93
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.